TearCare and Lipiflow yield similar results in treating meibomian gland disease and dry eye
- Posted on: Apr 27 2022
- Leave a response
A trial examines the difference between a single treatment of TearCare or Lipiflow to treat patients with meibomian gland disease and dry eye.
Source: AAO
Posted in: Uncategorized
